FindTrial
Sign In

A clinical trial of Tacrolimus as a therapeutic agent for atopic dermatitis in Chinese children: objective assessment of clinical efficacy in itch reduction and immunomodulatory effects

A clinical trial of Tacrolimus as a therapeutic agent for atopic dermatitis in Chinese children: objective assessment of clinical efficacy in itch reduction and immunomodulatory effects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000738
Enrollment
Unknown
Registered
2010-05-04
Start date
2005-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin and Connective Tissue Diseases

Interventions

Two groups:Topical Tacrolimus 2-4 weeks vs placebo

Sponsors

Departmetn of Paediatrics, CUHK
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Patients with eczema, aged 2 to 15 years

Exclusion criteria

Exclusion criteria: As stated before

Design outcomes

Primary

MeasureTime frame
SCORAD;—

Secondary

MeasureTime frame
DigiTrac recording, chemiokines;—

Countries

China

Contacts

Public ContactKam lun HON
email@mail.com+852 26322859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026